DNMT1 and head and neck carcinoma: Studies have shown that combined inhibition of DNMT activities using 5-AzaC and JAK signaling, both in vitro and in vivo, results in long-term reversion of CAF-associated preinvasive activity and restoration of the wild-type fibroblast phenotype in lung, head, and neck carcinoma [49].